To amend the Federal Food, Drug, and Cosmetic Act to authorize the use of investigational individualized medical treatments by patients diagnosed with a life-threatening disease or condition or severely debilitating illness, and for other purposes.
119-hr9190 — To amend the Federal Food, Drug, and Cosmetic Act to authorize the use of investigational individualized medical treatments by patients diagnosed with a life-threatening disease or condition or severely debilitating illness, and for other purposes.. Sponsored by Rep. Harshbarger, Diana [R-TN-1]. Introduced 2026-06-08. House bill. 119th Congress. Latest action: Referred to the House Committee on Energy and Commerce.
Bill Activity
House
Introduced
2026-06-08
Introduced in House
Referred to Committee
Referred to the House Committee on Energy and Commerce.
Committee
2026-06-08
Referred to the House Committee on Energy and Commerce.
- Sponsor
- Rep. Harshbarger, Diana [R-TN-1] (R), TN
- Introduced
- 2026-06-08
- Committees
- Energy and Commerce Committee
- Latest Action
- Referred to the House Committee on Energy and Commerce.
No roll-call vote data available for this bill.
Explore This Bill
Investigate this bill → AI summary, roll-call breakdown, and full bill analysis